'Calls to boycott Chinese goods in India won't have political effect

October 20, 2016

Beijing, Oct 20: A campaign to boycott Chinese goods in India due to differences over India's bid for NSG membership and UN ban on JeM chief Masood Azhar will not have much "political effect" and will fail to "fundamentally change the bilateral trade ties, state-run Chinese media said today.china-products

Quoting Indian media reports, an article in the state-run Global Times said that "some politicians and citizens in India have recently launched campaigns to boycott Chinese products".

"They blame China for India's failure to enter the Nuclear Suppliers Group (NSG), and for Beijing blocking India's UN bid on sanctioning a commander in Lashkar-e-Taiba, a Pakistan-based military group.

"Beijing and New Delhi are currently negotiating about these two issues and it is believed that mutual understanding will be reached eventually," said the article written by Liu Xiaoxue, an associate research fellow at the Institute of Asia-Pacific Studies at the Chinese Academy of Social Sciences said.

India is seeking a UN ban on Azhar, chief of Pakistan-based Jaish-e-Muhammad (JeM) which has been blamed for the January 2 Pathankot attack.

Scuttling India's move, China has recently put a second technical hold on Azhar's UN ban issue.

Underlining that Sino-Indian relationship has always been "haunted" by border disputes and China's ties with Pakistan, the article, said, "However, the two sides have long realised that setting aside divergences is beneficial for both sides' overall development than being hostile to each other."

"...A boycott of Chinese goods will not only result in little of the political effect that people who initiated the movement would like to see, but will also fail to fundamentally change India's current trade ties with China. In the end, it will be nothing more than a tiny incident," it said.

Referring to improvement in India-China political ties since the visit of former prime minister Rajiv Gandhi in 1988, the daily said economic and trade ties have also been boosted following which China has become India's largest trading partner since 2013.

"Of course, apart from political issues, some economic factors have also disrupted Sino-Indian trade development. Unresolved problems between the two nations sometimes influence their political mutual trust and have led to the non-tariff barriers in India against Chinese capital and products, such as security checks in major projects in the fields of defence, telecommunications, Internet and transportation," it said.

On the growing trade deficit, the daily said, "Economically, India has unbalanced trade ties with China. The increasing trade deficit with China has been irritating New Delhi. India's trade deficit with China jumped to USD 51.45 billion in 2015."

"As a country with a long-term account deficit which faces balance of payments problems, India is always vigilant against trade deficits. Chinese products can hence be easily turned into the target of India's anti-dumping sanctions," it said.

"After Indian Prime Minister Narendra Modi started promoting the slogan 'Make in India', some of the country's media and citizens have tended to hype up the substantial quantities of made-in-China balloons, coloured lanterns and ribbons that always appear in the nation's Hindu spring festival by asking, 'should our valuable foreign currency be wasted on these products?' or 'Are Indian manufacturing industries too backward to produce those goods?" it said.

"However, for consumers, attractive goods with a reasonable price are naturally their first option. Moreover, the merchandise, which is mentioned by Indian media all the time, is only a small part of Chinese exports to India," the daily said.

"Being a major exporter of high-tech goods, today's China mainly exports high-tech products to India, including electrical equipment, telecommunications equipment, train locomotives, computers and telephones. These are all necessary for India's economic development and its people's everyday lives," it said.

"Will Indian people answer the call of boycott? How long can the campaign last? What specific influence will it have on Sino-Indian trade relations? Even the Indian media pushing for a ban does not have the answers," the daily said.

"It is believed that after this round of patriotic passion, businessmen and consumers in India will make a rational choice," it said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 11,2020

Jun 11: The total death toll in the US from the novel coronavirus pandemic could hit the grim figure of 200,000 by September and expecting a dramatic decrease in COVID-19 cases in the country will be a "wishful thinking , an eminent Indian-American professor has warned.

Ashish Jha, the head of Harvard's Global Health Institute, told CNN on Wednesday that he is not trying to scare people to stay at home rather urged everyone to wear masks, adhere to the social distancing rules and called for ramping up testing and tracing infrastructure.

Anybody who's expecting a dramatic decrease in cases is almost surely engaging in wishful thinking. And if it (COVID numbers) stays just flat for the next three months, we're going to hit 200,000 deaths sometime in September and that is just awful, Jha said.

Jha said the 200,000 death toll is not just a guess . Currently 800-1000 people are dying daily in America from the virus and all data suggest that the situation is going to get worse.

We're gonna have increases, but even if we assume that it's going to be flat all summer, that nothing is going to get worse... even if we pick that low number of 800 a day, that is 25,000 (deaths) a month in three and a half months. We're going to add another 88,000 people and we will hit 200,000 sometime in September, Jha said.

The United States is by far the hardest-hit country in the global pandemic, in terms of both confirmed infections and deaths.

According to data by the Johns Hopkins University, the number of coronavirus cases in the US currently is nearly two million and about 112,900 people have died in the country, the most in the world.

When asked about an improvement in states like New York, which had been the epicenter of the COVID19 pandemic in the US, Jha said while coronavirus cases are declining in New York, New Jersey, Connecticut and Massachusetts, the numbers are increasing in states such as Arizona, Florida, Texas, North and South Carolina while the country as a whole is pretty flat.

He said, people should take measures as that will help suppress the virus and ensure people could get back outside safely but he voiced concern that this was not the situation in reality.

We're not doing that and so we're going to unfortunately have another 25,000 deaths a month until September, and then it'll keep going. It's not going to magically disappear. We've got a turn around. This is not the future I want, he said.

Jha said he had expected the situation to improve in the summer months but on the contrary the numbers have continued to rise even in the warm weather.

Summer was supposed to be our better months - warmer weather, people outside, a little less transmission. This is not the time (summer) I was expecting a lot more cases. We're seeing a lot more cases, especially in states like Arizona where the numbers look really scary, he said.

Jha added that he was hopeful that maybe the summer months would give us more of a break. I think I may have been too optimistic on that.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 20,2020

Paris, Jul 20: Two coronavirus vaccine candidates have proven safe for humans and produced strong immune reactions among patients involved in separate clinical trials, doctors said on Monday.

The first trial among more than 1,000 adults in Britain found that the vaccine induced "strong antibody and T cell immune responses" against the novel coronavirus.

A separate trial in China involving more than 500 people showed most had developed widespread antibody immune response.

The studies, published in The Lancet medical journal, constitute a major step on the road towards a COVID-19 vaccine that is effective and safe for widespread use.

The authors of the studies said that they encountered few adverse side-effects from the vaccine candidates.

However, they cautioned that more research was needed, particularly among older adults, who are disproportionately at risk of dying of COVID-19.

Co-author Sarah Gilbert from the University of Oxford said the results "hold promise".

"If our vaccine is effective, it is a promising option as these types of vaccine can be manufactured at large scale."

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 22,2020

London, Apr 22: The UK government on Tuesday announced a 20 million pounds funding for a University of Oxford project working on developing a vaccine against the novel coronavirus, which is now ready for acceleration as it begins human trials from Thursday.

UK Health Secretary Matt Hancock told the daily Downing Street briefing that the Department for Health was “throwing everything” at trying to find a vaccine because it is a critical aspect of the COVID-19 pandemic fight and lifting the strict lockdown measures in place to curb its spread.

Another 22.5 million pounds is being made available to Imperial College London to support its phase-two clinical trials for them to begin the work on a very large phase three trial.

"Normally it would take years to get to this point," said Hancock.

"The UK is at the forefront of the global effort – we've put in more money than any other into the global search for a vaccine. Nothing about this is inevitable. Vaccine production is a matter of trial and error. But the UK will throw everything it has at trying to find one,” he said.

The announcement came as Britain had another major daily leap in the hospital death toll from coronavirus, up by 823 to hit 17,337 on Tuesday.

But the Cabinet minister said the government's plan to control the rapid spread of the virus and prevent the state-funded National Health Service (NHS) from being overwhelmed is working as the number of hospitalisations with COVID-19 was showing a downward trajectory.

In reference to a major issue in the last few weeks of a critical shortage of personal protective equipment (PPE) for doctors and nurses on the frontlines of COVID-19 treatment, the minister said the supply problems are being addressed by actively engaging with thousands of companies, including 159 UK manufacturers.

“We are determined to get people the PPE they need. This is a 24/7 operation, one of the biggest cross-government operation I have ever seen," said Hancock.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.